The IARC evaluation was criticized by Cole and colleagues (2003) who stressed the lack of an overall increase in cancer risk in humans exposed to TCDD, the inconsistent selection of highly exposed groups in the IARC evaluation, and the weak evidence that the Ah receptor mediates multiorgan carcinogenicity. The gene discussed is AHR; the disease is cancer.